This contract modification is the first of three 30-month period options for McKesson to provide these services, according to a statement.
Through the contract, McKesson will provide pharmaceuticals for 9.5 million active-duty service members, retirees and their dependents through Dec. 16, 2017.
More articles on health IT:
Cerner CEO Neal Patterson testifies before Senate on HIEs: 4 key thoughts
More than 50% of healthcare providers do not have HIT roadmaps: 9 key findings
Cerner CEO testifies before Senate; Epic’s Judy Faulkner pledges 99% of wealth to charity; athenahealth and McKesson named top RCM firms — 7 health IT company key notes
